NextPlat (NXPL) Operating Expenses (2010 - 2026)
NextPlat's (NXPL) quarterly Operating Expenses came in at $4.8 million in Q2 2026, up 2.31% year-over-year from $4.7 million in Q2 2025, and up 6.78% quarter-over-quarter from $4.5 million in Q1 2026.
Analysis
NextPlat (NXPL) Operating Expenses (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Operating Expenses for 16 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Expenses rose 2.31% year-over-year to $4.8 million in Q2 2026; TTM through Jun 2026 was -$1.8 million, a 174.28% decrease from a year earlier, with the FY2025 full-year figure at $19.9 million, down 50.28% from the prior year.
- Operating Expenses was $4.8 million for Q2 2026 at NextPlat, up from $4.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $27.9 million in Q2 2024 and troughed at -$30.6 million in Q4 2024.
- A 5-year average of $4.4 million and a median of $4.8 million in 2025 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses surged 559.95% in 2023 and sank 671.73% in 2024, its largest moves.
- Over 5 years, Operating Expenses stood at $3.1 million in 2022, then surged by 71.72% to $5.3 million in 2023, then slumped by 671.73% to -$30.6 million in 2024, then grew by 11.91% to -$26.9 million in 2025, then soared by 117.91% to $4.8 million in 2026.
- The last three Operating Expenses figures came in at $4.8 million (Q2 2026), $4.5 million (Q1 2026), and -$26.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 1.29 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.45 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 356.56 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 195.34 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 2.11 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 225.58 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -65.41 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 53.74 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 16.14 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 4.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.82 Mn |
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | -26.91 Mn |
| Sep 30, 2025 | 15.74 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | -30.55 Mn |
| Sep 30, 2024 | 23.37 Mn |
| Jun 30, 2024 | 27.89 Mn |
| Mar 31, 2024 | 6.71 Mn |
| Dec 31, 2023 | 5.34 Mn |
| Sep 30, 2023 | 18.77 Mn |
| Jun 30, 2023 | 6.31 Mn |
| Mar 31, 2023 | 4.11 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 2.73 Mn |